AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05054153 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: refined carbohydrate breakfast
Description: After wearing CGM on Day 1, participants will be provided with breakfast A once daily on Day 2, Day 5 and Day 6. Breakfast A contains white bread (50g) and milk powder (25g). Since lunch and dinner would serve as wash-out meals, participants will be free to choose food but provide a record of their diets.
Study NCT05054153 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: whole grain breakfast
Description: After wearing CGM on Day 1, participants will be provided with Breakfast B once daily on Day 3, Day 4 and Day 7. Breakfast B contains plain oats (35g) and milk powder (25g). Since lunch and dinner would serve as wash-out meals, participants will be free to choose food but provide a record of their diets.
Study NCT05054153 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: intermittent fasting
Description: The period during Day 8 to Day 13 is intermittent fasting period. Participants will experience the moderate fasting on Day 9 and Day 12, which means their daily energy intake is expected to be controlled within 500-600 kcal limit. In these two days, participants will be provided with all three meals. Percentages of macronutrients of provided meals will follow the Recommended Dietary Health guidelines for Chinese residents. The oral glucose tolerance test (OGTT) will be conducted in the morning on Day 8 and Day 13, to test short-term impact of IF intervention on individuals' glucose tolerance. The breakfasts on Day 10 and Day 11 will be the same as that in fasting days. Other meals will be wash-out meals.
Study NCT05712473 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: PYLARIFY
Description: PYLARIFY PET
Study NCT05550701 — intervention group
Intervention type: OTHER
Intervention: lymph node yield
Description: We recorded the number of lymph nodes dissected during surgery in patients with colorectal cancer
Study NCT05064683 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: white noise
Description: Newborns in the control group did not receive any treatment other than routine applications while receiving nasal CPAP support in the neonatal intensive care unit.The newborns in the faciliated tucking group were given supine, prone, and lateral positions for 24 hours, depending on their clinical status.The newborns in the white noise group were listened to white noise for 24 hours using an Mp3 player and a decibel measuring device to measure the sound level.
Study NCT05665465 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine nasal spray 0.5 mg
Description: Participants will be administered nicotine nasal spray and provide subjective reactions
Study NCT05665465 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Participants will be administered placebo nasal spray and provide subjective reactions
Study NCT05665465 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will be administered placebo nasal spray and provide subjective reactions
Study NCT04952454 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: External Dacryocystorhinostomy
Description: The resistance of the lacrimal drainage is lowered by creating a new ostium between the lacrimal sac and nasal cavity via skin incision.
Study NCT04952454 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endonasal Dacryocystorhinostomy
Description: The resistance of the lacrimal drainage is lowered by creating a new ostium between the lacrimal sac and nasal cavity via endonasal route.
Study NCT04952454 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Transcanalicular Dacryocystorhinostomy
Description: The resistance of the lacrimal drainage is lowered by creating a new ostium between the lacrimal sac and nasal cavity via transcanalicular route.
Study NCT06587971 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Oral hygiene education
Description: Providing guidance on proper brushing techniques, smoking cessation, dietary control, and blood sugar management.
Study NCT06587971 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Oral hygiene education
Description: Providing guidance on proper brushing techniques, smoking cessation, dietary control, and blood sugar management.
Study NCT06597305 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Twenty Session Cognitive-Behavioral Therapy for Anorexia Nervosa (CBT-20-AN)
Description: Twenty session cognitive behavioral therapy for Anorexia Nervosa (CBT-20-AN) is an treatment for Anorexia Nervosa delivered by a mental health clinician. This treatment (CBT-20-AN) lasts just 20 sessions and has been designed to allow individuals with AN to reap the benefits of CBT for eating disorders (up to 40 sessions) in less time, increasing access to care and shortening time to symptom reduction.
Study NCT06586645 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Safety Planning
Description: Safety planning is a standard suicide risk assessment and management protocol. This protocol involves determining level of risk based on current and prior suicidal thoughts and behavior, and then collaborative planning with youth and families for self-monitoring, self-regulation, help seeking, and suicide means restriction.
Study NCT06151223 — intervention group
Intervention type: OTHER
Intervention: Bio-specimen Collection: Blood
Description: At study enrollment and prior to any pancreatic surgery and prior to or at least 3 days after the most recent GI endoscopy procedure, approximately 50 ml (10 teaspoons) of blood will be drawn from all participants and be processed according to standardized study biospecimen protocol. Serial blood collection will be offered to all the participants depending on the subjects' tier classification. Blood draw will be completed at Mayo Clinic when the subjects come back, or study blood draw kit may be sent for external collection.
Study NCT06586645 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Safety Planning
Description: Safety planning is a standard suicide risk assessment and management protocol. This protocol involves determining level of risk based on current and prior suicidal thoughts and behavior, and then collaborative planning with youth and families for self-monitoring, self-regulation, help seeking, and suicide means restriction.
Study NCT06586645 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Give to Others Module
Description: The Give to Others Module is a brief cognitive behavioral intervention targeting youth burden-related beliefs. It consists of one primary session and brief phone follow-up.
Study NCT06596161 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iron sucrose
Description: Receving iron
Study NCT06596161 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05727306 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: Observational analysis of usual care only.
Study NCT06151223 — intervention group
Intervention type: OTHER
Intervention: Bio-specimen Collection: Pancreatic Juice
Description: This may be collected from research subjects every time they are undergoing a clinically indicated endoscopic ultrasound (EUS), endoscopic retrograde cholangiopancreatography (ERCP) or upper gastrointestinal endoscopy (EGD) procedure. Pancreatic juice will not be collected if PI or provider determines it is not in the best interest of the subject. Pancreatic juice collection will be performed prior to fine needle aspiration (FNA), brushing or stent placements if performed during the same endoscopic procedure.
Study NCT05056415 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Everyday Life Rehabilitation (ELR)
Description: Everyday Life Rehabilitation (ELR) is an intervention model for integrated occupational therapy in close collaboration with housing staff in sheltered and supported housing facilities (Lindström, 2007; 2011), aiming at personal recovery and engagement in meaningful everyday activities for persons with SPD. The mediators are: personcentred, motivational, recovery- and activity-based methods, negotiation of user goal priority and expected outcome; methods for training in real-life situations; devices for collaboration; support from staff on an everyday basis; and an educational package including web-sections, manuals, and collegiate tutorial.~The language and actions of professionals promote hope, self-discovery and shared-decision making, shaped in partnership with residents. The resident is also encouraged to access different resources outside of health and social care such as family, peer and social support, out-of-housing strategies, and sources in the open society.
Study NCT05056415 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as usual (TAU)
Description: No standardized instructions about the efforts is given to staff at the accommodations. Usually, only short terms efforts are offered to residents, such as prescribing technical aids.
Study NCT06596343 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adjuvant Chemotherapy Combined with Traditional Chinese Medicine (TCM) Supportive Therapy
Description: 1. Chemotherapy Regimen:~   * Postoperative adjuvant chemotherapy: A dual-drug concurrent regimen will be used, with each cycle lasting 21 days. On day 1 of each cycle, oxaliplatin will be administered intravenously at a dose of 130 mg/m². From day 1 to day 14 of each cycle, capecitabine will be taken orally at a dose of 1000 mg/m², twice daily. The treatment duration will follow the CSCO 2023 guidelines for colorectal cancer, with chemotherapy lasting for 6 months.~2. TCM Treatment:~   * TCM treatment will be based on syndrome differentiation (Zheng) and guided by the Guidelines for TCM Diagnosis and Treatment of Malignant Tumors.
Study NCT06588543 — intervention group
Intervention type: DEVICE
Intervention: Endovascular treatment
Description: Endovascular treatment
Study NCT06598020 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Supportive Care
Description: Competency-based training purposed to alleviate anxiety relief using a mind-body modality and improve pain with touch modalities (e.g., acupressure)
Study NCT06603428 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: internal fixation by plate or screws
Description: - Patients more than 5 ml displacement of GT fracture (3ml in active highly demanded patient) are for internal fixation, others less this are for conservative management.
Study NCT06591091 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clemastine Fumarate
Description: Listed in arm/group description
Study NCT06591091 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Clemastine Fumarate
Description: Listed in arm/group description
Study NCT06595199 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Online peer support
Description: A closed online peer support group
Study NCT06589037 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: shock wave treatment control group
Description: The control group, consisting of 24 people, will receive shock wave treatment on the sole of the foot to treat plantar fasciitis. There will be 4 sessions and 4 data collections.
Study NCT06589037 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: shock wave treatment experimental group
Description: The experimental group, consisting of 24 people, will receive shockwave treatment on the back of the leg to treat plantar fasciitis. There will be 4 sessions and 4 data collections.
Study NCT06604052 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Reduced-Port Fusion Surgery
Description: (1) The Joint Trocar/Stoma Zone will be delineated by the stoma therapist. (2) The placement of the fusion point will involve collaboration between the surgeon and stoma therapist. This will be based on the surgeon\&#39;s trocar placement plan and the stoma therapist\&#39;s positioning principles. (3) Follow the principles of modified stomal positioning. (4) The surgeon will insert the main trocar based on the preoperative positioning point. During stoma creation, the 12 mm main trocar incision will be extended to 25-30 mm to create an ileostomy.
Study NCT06604052 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Traditional surgery
Description: (1) The stoma therapists perform stoma positioning using traditional stoma positioning method. The surgeon will determine the primary trocar location, ensuring it does not overlap with the stoma site. (2) The surgeon will insert the primary trocar based on the preoperative positioning point and conduct the surgery. During stoma creation, the surgeons create ileal stoma according to the preoperative stoma positioning point.
Study NCT06599905 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Episodic Migraine (EM)
Description: Three stimulus offset trials (OT) and three constant temperature trials (CT) applied to the forehead based on the individual heat pain threshold (HPT).
Study NCT06599905 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Episodic Migraine (EM)
Description: Three stimulus offset trials (OT) and three constant temperature trials (CT) applied to the forehead based on the individual heat pain threshold (HPT).
Study NCT06599905 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Chronic Migraine (CM)
Description: Three stimulus offset trials (OT) and three constant temperature trials (CT) applied to the forehead based on the individual heat pain threshold (HPT).
Study NCT06599905 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chronic Migraine (CM)
Description: Three stimulus offset trials (OT) and three constant temperature trials (CT) applied to the forehead based on the individual heat pain threshold (HPT).
Study NCT05767749 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: lidocaine + epinephrine 1:100,000
Description: 0.5 ml lidocaine + epinephrine 1:100,000, buffered 1/10 with sodium bicarb.
Study NCT05767749 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.5% Injectable Solution
Description: 0.5 ml Ropivacaine 0.5% Injectable Solution
Study NCT06151223 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: MRI
Description: A research MRI with contrast that includes a Magnetic Resonance Cholangiopancreatography (MRCP) will be offered to patients in the Tier 2 cohort at baseline and at 3-year intervals if not done as standard of care. Gadolinium based intravascular contrast will be administered for this procedure. Sedation for claustrophobia/anxiety per clinical protocol will be an option if the patients requested. Subject would be notified of any concerning results. A safety questionnaire will be completed by the study team before ordering the MRI.~Clinically indicated MRIs for the TIER 1 participants will be used and collected as part of the registry.~If a clinical MRI/MRCP has been performed between 0 to 3 months before obtaining consent, the prior clinical MRI/MRCP could be used to obtain baseline imaging data.
Study NCT05830045 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QLP2117
Description: Specified dose on specified days
Study NCT04987086 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: PSMA PET
Description: PSMA PET may have influence on the clinical decision-making of the patients with renal cancer
Study NCT05332145 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: MAP to Health
Description: In Phase 1, participants will complete the web-based interview and Aim 1 measures, assessing acceptability and usability of the intervention. The investigators will review whether the intervention appropriately gathers information needed to program theory-based, personalized text messages. After completing the measures, a list of text messages for that participant will be generated and sent to the participant for review. Participants will review the text messages and rate the extent to which the messages are personalized. In Phase 2, the investigators will conduct a proof-of-concept pilot trial in which participants will complete a 4-week pretest monitoring period and an 8-week pilot trial of the intervention, with assessments of Self-Determination Theory mechanisms and meaning salience at pretest (-4 weeks), baseline (0 weeks), midpoint (4 weeks) and posttest (8 weeks). In addition, participants will wear accelerometers to assess physical activity during the 12 weeks.
Study NCT05169138 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Aromatherapy application /massage with lavender oil
Description: The application was applied to 37 pregnant women in total, and the effect of massage with lavender oil on labor pain was investigated.
Study NCT05169138 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Aromatherapy application / inhalation with lavender oil
Description: The application was applied to 41 pregnant women in total, and the effect of inhalation with lavender oil on labor pain was investigated.
Study NCT05425628 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NeoChord Transcatheter Mitral Repair System (or NeoChord System)
Description: The NeoChord Transcatheter Mitral Repair System is a system of delivery devices and implantable Neochordae and Anchor. The system is designed to percutaneously deliver and deploy the implantable ePTFE sutures, Neochordae as artificial chordae at the mitral valve and connect them to the implantable ventricular anchor, Anchor, using a catheter based system placed into the left side of the heart through the interatrial septum.
Study NCT05767749 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.5% Injectable Solution
Description: 0.5ml bupivacaine 0.5%
Study NCT05173740 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Individually tailored rehabilitation intervention
Description: Individually tailored rehabilitation intervention
Study NCT05173740 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Usual care
Description: Usual care
Study NCT06057675 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Treatment (tranexamic acid and 1% lidocaine with 1:100,000 epinephrine)
Description: Subcutaneous injection of local anesthetic (1% lidocaine with 1:100,000 epinephrine) and tranexamic acid (1g/10mL), mixed in a 9:1 volume ratio.
Study NCT06057675 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Control (1% lidocaine with 1:100,000 epinephrine)
Description: Subcutaneous injection of local anesthetic (1% lidocaine with 1:100,000 epinephrine)
Study NCT06592872 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Bullying prevention
Description: The intervention utilizes a serious (educational) videogame and teacher-led, interactive class sessions. Students exposed to the intervention will learn to respond to in-person and online bullying from the perspectives of perpetrator, victim, and bystander. The intervention enhances personal self-management skills, social skills, refusal skills, and other life skills needed to successfully navigate developmental tasks, increase resilience, and facilitate healthy psychosocial development.
Study NCT06599918 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Nicotinamide
Description: Administration of NAM on a variable dose depending on the participant's body weight. Administration is done orally, daily.
Study NCT06599918 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administration of placebo on a variable dose depending on the participant's body weight. Administration is done orally, daily.
Study NCT06542835 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Video text message
Description: Video text messages tailored to the Latinx population to educate and motivate patients to complete CRC screening.
Study NCT06542835 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: In-clinic CRC screening promotion
Description: Stool-test orders, colonoscopy referrals.
Study NCT06542835 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mailed FIT
Description: Mailed FIT kits.
Study NCT06542835 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social needs navigation
Description: Patient navigation to address social needs.
Study NCT06542835 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Reminders
Description: Centralized text and/or telephone reminders for ordered tests.
Study NCT06590194 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PH009-1 tablet
Description: PH009-1 will be administered in fasting state
Study NCT06604065 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AMS2434 (amino acids)
Description: The proprietary composition includes leucine, valine, isoleucine, lysine, phenylalanine, threonine, tyrosine, histidine, and methionine. Small amounts of non-caloric flavorings are also included.
Study NCT06604065 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matched non-caloric placebo. Study products will be in powder form and packaged in individual serving sizes and will be dissolved in 8 oz water for consumption.
Study NCT06585852 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RGD
Description: Study group main material
Study NCT06585852 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Xenograft
Description: Scaffold material of choice
Study NCT06585852 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Xenograft
Description: Scaffold material of choice
Study NCT06585852 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Split crest technique
Description: Piezoelectric surgery
Study NCT06585852 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Split crest technique
Description: Piezoelectric surgery
Study NCT06597318 — intervention group
Intervention type: OTHER
Intervention: Hospitalization
Description: The investigators collect PROMs amongst up to 1000 patients in general internal medicine divisions of all five Swiss university hospitals
Study NCT06585956 — intervention group
Intervention type: BEHAVIORAL
Intervention: Comminication via Telemedicine
Description: Comminication via Telemedicine With Patients